Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 25 of 27
 |<   <<   <  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27

Scientific Advancements
Thursday, August 31, 2017   (0 Comments - view/add)
Oragenics Doses First Patient in Phase 2 Clinical Trial of AG013 for Oral Mucositis »
Oragenics Doses First Patient in Phase 2 Clinical Trial of AG013 for Oral Mucositis Download as PDF August 3...
Friday, August 25, 2017   (0 Comments - view/add)
Heart hormones protect against obesity and insulin resistance »
Public Release:  25-Aug-2017 Heart hormones protect against obesity and insulin resistance Elevated levels o...
Tuesday, August 22, 2017   (0 Comments - view/add)
Jupiter Orphan Therapeutics Receives Orphan Drug Designation for its Trans-Resveratrol Product JOTRO »
Jupiter Orphan Therapeutics Receives Orphan Drug Designation for its Trans-Resveratrol Product JOTROL for Treatment of Fri...
Tuesday, August 22, 2017   (0 Comments - view/add)
Lakewood-Amedex Inc. Completes Clinical Trial Recruitment for Final Cohort of the Company's Phase 1/ »
Lakewood-Amedex Inc. Completes Clinical Trial Recruitment for Final Cohort of the Company's Phase 1/2a Program in Patients...
Tuesday, August 8, 2017   (0 Comments - view/add)
TapImmune Amends Phase 2 Clinical Trial to Focus on Larger Population of Women with Platinum-Sensiti »
TapImmune Amends Phase 2 Clinical Trial to Focus on Larger Population of Women with Platinum-Sensitive Ovarian Cancer with...
Thursday, August 3, 2017   (0 Comments - view/add)
Moffitt: New Research Shows the Power of Radiomics to Improve Precision Medicine »
August 3, 2017   Moffitt: New Research Shows the Power of Radiomics to Improve Precision Medicine &n...
Thursday, August 3, 2017   (0 Comments - view/add)
AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigment »
Source: Applied Genetic Technologies Corporation August 3, 2017   AGTC Announces U.S. FDA Orphan Drug...
Monday, July 24, 2017   (0 Comments - view/add)
Xcovery Collaborates with the National Cancer Institute and Children’s Oncology Group for The NCI-CO »
Xcovery Collaborates with the National Cancer Institute and Children’s Oncology Group for The NCI-COG Pediatric MATCH Clin...
Friday, July 14, 2017   (0 Comments - view/add)
StemSynergy Announces Breakthrough in Colorectal Cancer Drug Development »
July 14, 2017 12:12 PM Eastern Daylight Time StemSynergy Announces Breakthrough in Colorectal Cancer Drug Developm...
Tuesday, June 27, 2017   (0 Comments - view/add)
TapImmune Reaches 50% Patient Enrollment Benchmark in Phase 2 Study of Novel T-Cell Vaccine Targetin »
TapImmune Reaches 50% Patient Enrollment Benchmark in Phase 2 Study of Novel T-Cell Vaccine Targeting Triple-Negative Brea...
Wednesday, June 21, 2017   (0 Comments - view/add)
CTD Holdings Enrolls First Patient in European Phase I/II Clinical Trial of Trappsol(R) Cyclo(TM) fo »
CTD Holdings Enrolls First Patient in European Phase I/II Clinical Trial of Trappsol(R) Cyclo(TM) for Treatment of Niemann...
Wednesday, June 21, 2017   (0 Comments - view/add)
Nephure™ Obtains Self-Affirmed GRAS Notification »
June 21, 2017 10:25 AM Eastern Daylight Time Nephure™ Obtains Self-Affirmed GRAS Notification Product ex...
Tuesday, June 20, 2017   (0 Comments - view/add)
Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer »
Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer TAMPA, Fla. , June 20, 2017 /P...
Thursday, June 15, 2017   (0 Comments - view/add)
IND-Enabling Study Data Published in Human Gene Therapy Clinical Development Support Clinical Develo »
IND-Enabling Study Data Published in Human Gene Therapy Clinical Development Support Clinical Development of AGTC-402 for...
Thursday, June 15, 2017   (0 Comments - view/add)
New pathways to cancer therapy »
New pathways to cancer therapy Repurposed antifungal agent exhibits promising efficacy and safety for BCCNS treatment...
Thursday, June 8, 2017   (0 Comments - view/add)
New Zika Test Produces Results In Under An Hour »
SOURCE:  http://health.wusf.usf.edu/post/new-zika-test-produces-results-under-hour#stream/0   New Zi...
Thursday, June 8, 2017   (0 Comments - view/add)
AGTC Announces Topline Safety Data for X-Linked Retinoschisis Phase 1/2 Study »
GAINESVILLE, Fla. and CAMBRIDGE, Mass., June 08, 2017 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ...
Wednesday, June 7, 2017   (0 Comments - view/add)
Aimmune Therapeutics Cuts Ribbon on Commercial Manufacturing Facility to Support Potential Launch of »
Aimmune Therapeutics Cuts Ribbon on Commercial Manufacturing Facility to Support Potential Launch of Treatment for Peanut...
Tuesday, May 30, 2017   (0 Comments - view/add)
Somahlution Announces DuraGraft Registry Initiation at Leading Cardiac Surgery Hospitals in Germany »
Somahlution Announces DuraGraft Registry Initiation at Leading Cardiac Surgery Hospitals in Germany The DuraGraf...
Tuesday, May 30, 2017   (0 Comments - view/add)
HedgePath Pharmaceuticals Announces Granting of Type-C Meeting Request by FDA and Provides Positive »
HedgePath Pharmaceuticals Announces Granting of Type-C Meeting Request by FDA and Provides Positive Clinical Trial Update...
Tuesday, May 30, 2017   (0 Comments - view/add)
HedgePath Pharmaceuticals Announces Granting of Type-C Meeting Request by FDA and Provides Positive »
HedgePath Pharmaceuticals Announces Granting of Type-C Meeting Request by FDA and Provides Positive Clinical Trial Update...
Thursday, May 25, 2017   (0 Comments - view/add)
Fruit Flies Journey to International Space Station to Study Effects of Zero Gravity on the Heart »
NEWS RELEASE Media Contacts: Susan Gammon, Ph.D. Sanford Burnham Prebys Medical Discovery Institute Office (858...
Wednesday, May 24, 2017   (0 Comments - view/add)
NovaBone Announces Irrigation Resistant Products with Carriers that have Synergistic Effect in Bone »
NovaBone Announces Irrigation Resistant Products with Carriers that have Synergistic Effect in Bone Formation May 24...
Tuesday, May 23, 2017   (0 Comments - view/add)
Exciting diabetes and obesity research highlights from Medical City »
NEWS RELEASE Media Contact: Deborah Robison Sanford Burnham Prebys Medical Discovery Institute Phone (407) 745-207...
Monday, May 22, 2017   (0 Comments - view/add)
Teewinot Life Sciences Corporation Announces New Cannabis Genome Research Program »
Teewinot Life Sciences Corporation Announces New Cannabis Genome Research Program Furthers Mission to Address Unmet Med...
Tuesday, May 16, 2017   (0 Comments - view/add)
Sanford Burnham Prebys Finds Molecule That Stops Deadly Zika from Spreading »
Sanford Burnham Prebys Finds Molecule That Stops Deadly Zika from Spreading POSTED BY   DEBBIE L. SKLAR &n...
Monday, May 15, 2017   (0 Comments - view/add)
Longeveron Announces Publication of Phase 1 Safety and Efficacy Trial Results for Allogeneic Stem Ce »
Longeveron Announces Publication of Phase 1 Safety and Efficacy Trial Results for Allogeneic Stem Cell Treatment in Frailt...
Wednesday, May 10, 2017   (0 Comments - view/add)
Longeveron Begins Enrollment of Second Cohort of Phase 1 Trial of Allogeneic Mesenchymal Stem Cells »
Longeveron Begins Enrollment of Second Cohort of Phase 1 Trial of Allogeneic Mesenchymal Stem Cells to Treat Alzheimer's D...
Tuesday, May 9, 2017   (0 Comments - view/add)
Biscayne Readies Phase 1b Trial for Novel Antiepileptic Agent BIS-001 and Receives FDA Orphan Drug D »
Biscayne Readies Phase 1b Trial for Novel Antiepileptic Agent BIS-001 and Receives FDA Orphan Drug Designation for Dravet...
Tuesday, May 9, 2017   (0 Comments - view/add)
AGTC and Collaborators Present New Data on the Natural History of X-Linked Retinoschisis (XLRS) at t »
AGTC and Collaborators Present New Data on the Natural History of X-Linked Retinoschisis (XLRS) at the Association for Res...
Wednesday, May 3, 2017   (0 Comments - view/add)
Mysterious Molecule’s Function in Skin Cancer Identified »
Mysterious Molecule’s Function in Skin Cancer Identified Non-coding RNA SPRIGHTLY plays important role in tumor growth...
Tuesday, May 2, 2017   (0 Comments - view/add)
Altor BioScience Corporation Announces FDA Fast Track Designation for Lead Candidate ALT-803 in Pati »
Altor BioScience Corporation Announces FDA Fast Track Designation for Lead Candidate ALT-803 in Patients with Non-Muscle I...
Tuesday, May 2, 2017   (0 Comments - view/add)
University of Miami Health System Starts Clinical Trial to Test Regenerative Treatment for Stroke »
University of Miami Health System Starts Clinical Trial to Test Regenerative Treatment for Stroke Pioneering study eval...
Monday, May 1, 2017   (0 Comments - view/add)
Cantex Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Development for CX-02 in Recur »
Cantex Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Development for CX-02 in Recurrent Glioblastoma...
Sunday, April 30, 2017   (0 Comments - view/add)

Displaying page 25 of 27
 |<   <<   <  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)